1. Home
  2. IRWD vs RPID Comparison

IRWD vs RPID Comparison

Compare IRWD & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • RPID
  • Stock Information
  • Founded
  • IRWD 1998
  • RPID 2006
  • Country
  • IRWD United States
  • RPID United States
  • Employees
  • IRWD N/A
  • RPID 163
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • RPID Medical Specialities
  • Sector
  • IRWD Health Care
  • RPID Health Care
  • Exchange
  • IRWD Nasdaq
  • RPID Nasdaq
  • Market Cap
  • IRWD 150.9M
  • RPID 155.6M
  • IPO Year
  • IRWD 2010
  • RPID 2021
  • Fundamental
  • Price
  • IRWD $0.63
  • RPID $3.49
  • Analyst Decision
  • IRWD Buy
  • RPID Buy
  • Analyst Count
  • IRWD 5
  • RPID 1
  • Target Price
  • IRWD $4.94
  • RPID $8.00
  • AVG Volume (30 Days)
  • IRWD 3.0M
  • RPID 163.7K
  • Earning Date
  • IRWD 05-07-2025
  • RPID 05-09-2025
  • Dividend Yield
  • IRWD N/A
  • RPID N/A
  • EPS Growth
  • IRWD N/A
  • RPID N/A
  • EPS
  • IRWD N/A
  • RPID N/A
  • Revenue
  • IRWD $317,676,000.00
  • RPID $29,645,000.00
  • Revenue This Year
  • IRWD N/A
  • RPID $18.54
  • Revenue Next Year
  • IRWD N/A
  • RPID $20.55
  • P/E Ratio
  • IRWD N/A
  • RPID N/A
  • Revenue Growth
  • IRWD N/A
  • RPID 28.36
  • 52 Week Low
  • IRWD $0.53
  • RPID $0.58
  • 52 Week High
  • IRWD $7.11
  • RPID $4.04
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 39.10
  • RPID 62.94
  • Support Level
  • IRWD $0.55
  • RPID $3.15
  • Resistance Level
  • IRWD $0.65
  • RPID $3.84
  • Average True Range (ATR)
  • IRWD 0.07
  • RPID 0.25
  • MACD
  • IRWD 0.02
  • RPID 0.01
  • Stochastic Oscillator
  • IRWD 37.04
  • RPID 54.08

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Share on Social Networks: